A single [3H]thymidine-based limiting dilution analysis to determine HTLp and CTLp frequencies for bone marrow donor selection

Bone Marrow Transplantation

Volumn 20, Issue 2, 1997, Pages 149-155

  Van Der Meer, A ^a   Joosten, I ^a   Ruiter, J ^a   Allebes, W A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cytotoxic T lymphocyte; Helper T lymphocyte; Limiting dilution analysis; 3H thymidine

Indexed keywords

CHROMIUM 51; THYMIDINE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE MARROW; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DILUTION; DONOR; GRAFT VERSUS HOST REACTION; HELPER CELL; HISTOCOMPATIBILITY; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LEUKOCYTE DIFFERENTIAL COUNT; PRIORITY JOURNAL; STEM CELL; T LYMPHOCYTE SUBPOPULATION; BONE MARROW TRANSPLANTATION; CYTOLOGY; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; INDICATOR DILUTION CURVE; ISOTOPE LABELING; LYMPHOCYTE COUNT; METABOLISM; METHODOLOGY;

BONE MARROW TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; INDICATOR DILUTION TECHNIQUES; ISOTOPE LABELING; LYMPHOCYTE COUNT; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; THYMIDINE; TISSUE DONORS;

EID: 0030612476     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700869     Document Type: Article

References (23)

1. DeGast GC, Mickelson EM, Beatty PG et al. Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia. Bone Marrow Transplant 1992; 9: 87-90.
2. Hows JM, Yin JL, Marsh J et al. Histocompatible unrelated volunteer donor compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemia. Blood 1986; 68; 1322-1328.
3. Mickelson EM, Lontgton G, Anasetti C et al. Evaluation of the mixed lymphocyte culture (MLC) assay as a method for selecting unrelated donors for marrow transplantation. Tissue Antigens 1996; 47: 27-36.
4. Irle C, D'Amaro J, van Rood JJ. Bone marrow transplantation from other than non-identical siblings. Bone Marrow Transplant 1992; 9: 87-90.
5. Schwarer AP, Jiang YZ, Deacock S et al. Comparison of helper and cytotoxic antirecipient T cell frequencies in unrelated bone marrow transplantation. Transplantation 1994: 58: 1 198-1203.
6. Theobald M, Nierle T, Bunjes D et al. Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings. New Engl J Med 1992; 327: 1613-1617.
7. Schwarer AP, Jiang YZ, Brookes PA et al. Frequency of antirecipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantation. Lancet 1993; 341: 203-205.
8. Freidel AC, Michallet M, Gebuhrer L et al. Study of HTLp in adult patients receiving bone marrow transplantation from HLA geno-identical sibs. Hum lmnuinol 1996: 47: 84 (Abstr.).
9. Kaminski E, Hows J, Man S et al. Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation. Transplantation 1989; 48: 608-613.
10. Spencer A, Brookes PA, Kaminski E et al. Cytotoxic T lymphocyte precursor frequency analyses in bone marrow transplantation with volunteer unrelated donors. Value in donor selection. Transplantation 1995: 59: 1302-1308.
11. Roosnek E, Hngendijk S, Zawadynski S, et al. The frequency of pretrunsplant donor cytotoxic T cell precursors with antihost specificity predicts survival of patients transplanted with bone marrow from donors other than HLA-identical siblings. Transplantation 1993: 56: 691-696.
12. Speiser DE, Löliger CC, Siren MK, Jennnet M. Pretransplant cytotoxic donor T-cell activity specific to patient HLA class I antigens correlating with mortality after unrelated BMT. Br J Haematol 1996: 93: 935-939.
13. Fussell ST, Donnellan M, Cooley MA, Farrell C, Cytotoxic T lymphocyte precursor frequency does not correlate with either the incidence or severity of graft-versus-host disease after matched unrelated donor bone marrow transplantation. Transplantation 1994: 57: 673-676.
14. Matzinger P, The JAM test. A simple assay for DNA fragmentation and cell death. J lmmunol Meth 1991: 145: 185-192.
15. De Lucu M, Moses JH, Marsh SGE, Bodmer JG, Identification of HLA-B*44 and HLA-B*45 alleles using a nested ARMSPCR method. Hum lmmunol 1996: 47: 9 (Abstr.).
16. Gillis S, Perm MM, Ou W, Smith KA, T cell growth factor: parameters of production and a quantitative microassay for activity. J lmmunol 1978; 120; 2027-2032.
17. Strijbosch LW, Buurman WA, Does RJ et al. Limiting dilution assays. Experimental design and statistical analysis. J lmmunol Meth 1987: 97: 133-140.
18. Theobald M. Allorecognition and graft-versus-host disease. Bone Marrow Transplant 1995: 15: 489-498.
19. Bouma GJ, Schanz U, Oudshoorn M et al. A cell-saving non-radioactive limiting dilution analysis-assay for the combined determination of helper and cytotoxic T lymphocyte precursor frequencies. Bone Marrow Transplant 1996: 17: 19-23.
20. Van Der Meer A, Ruiter J, Joosten I, Allebes WA. Determination of CTLp and HTLp frequencies in a single limiting dilution assay. Immunology 1995; 86: 64 (Abstr.).
21. Reisaeter AV, Thorsby E, Brinchmann JE. Analysis of alloreactive helper T lymphocyte precursor frequencies. Influence of interleukin-2 produced by the stimulating cells. J Immunol Meth 1996: 189: 65-72.
22. Schanz U, Roelen DL, Binning JW et al. The relative radioresistance of interleukin-2 production by human peripheral blood lymphocytes: consequences for the development of a new limiting dilution assay for the enumeration of helper T lymphocyte precursor frequencies. J lmmunol Meth 1994: 169: 221-230.
23. Hornick P, Brookes PA, Mason P et al. Limiting dilution analysis: increasing the sensitivity and specificity of the alloreactive t helper cell assay by abrogating 'unwanted' IL-2 production. Hum Immunol 1996; 47: 130 (Abstr.).